GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Weekly CFO Buys Highlight: POL, ARAY, ZBB, CRMD, VRX

December 18, 2011 | About:
gurujk

gurujk

5 followers
According to GuruFocus Insider Data, the largest CFO buys during the past week were PolyOne Corp., Accuray Inc., ZBB Energy, CorMedix Inc. and Valeant Pharmaceuticals International Inc.

PolyOne Corp. (POL): Executive Vice President and CFO Robert M. Patterson Bought 30,000 Shares

Executive Vice President and CFO of PolyOne Corp. (POL) Robert M. Patterson bought 30,000 shares on 12/08/2011 at an average price of $11. PolyOne Corporation is an international polymer services company with operations in thermoplastic compounds, specialty resins, specialty polymer formulations, engineered films, color and additive systems, elastomer compounding and thermoplastic resin distribution. Polyone Corp. has a market cap of $959.2 million; its shares were traded at around $11 with a P/E ratio of 10.1 and P/S ratio of 0.4. The dividend yield of Polyone Corp. stocks is 1.4%.

PolyOne Corporation reported revenues of $735.8 million for the third quarter of 2011, an 8% increase compared to revenues of $680.8 million in the third quarter of 2010. Diluted earnings per share totaled $0.23 in the third quarter of 2011, compared to $0.04 per diluted share in the third quarter of 2010. Adjusted earnings per share increased 10% to $0.26 for the third quarter of 2011 up from $0.24 recorded in the third quarter last year.

Executive Vice President and CFO Robert M Patterson, Director William Howard Powell, and Director Richard A. Lorraine bought shares of POL stock.

Accuray Inc. (ARAY): Senior Vice President and CFO Derek A. Bertocci Bought 10,000 Shares

Senior Vice President and CFO of Accuray Inc. (ARAY) Derek A. Bertocci bought 10,000 shares on 12/13/2011 at an average price of $4.08. Accuray Inc., based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray Inc. has a market cap of $305.5 million; its shares were traded at around $4.21 with and P/S ratio of 1.4.k President &

CEO Euan Thomson, Senior Vice President and COO Chris Raanes, and Senior Vice President and General Counsel Darren J. Milliken sold shares of ARAY stock.

ZBB Energy (ZBB): CFO William C. Hogoboom Bought 14,000 Shares

CFO of ZBB Energy (ZBB) William C. Hogoboom bought 14,000 shares on 12/13/2011 at an average price of $0.75. ZBB Energy Corporation develops and manufactures distributed energy storage solutions based on the company's proprietary zinc-bromine rechargeable electrical energy storage technology. Zbb Energy has a market cap of $20.2 million; its shares were traded at around $0.745 with and P/S ratio of 11.2.

ZBB Energy Corporation reported increased quarterly revenues of $1,637,857 compared to $0 for the same quarter last year and also compared to $1,802,610 for the entire year ended June 30, 2011. Net loss for the three months ended September 30, 2011 decreased by $358,854 to $1,675,448 from the $2,034,302 net loss for the three months ended September 30, 2010.

CFO William C. Hogoboom, Director Manfred E. Birnbaum, Vice President System Engineer and Dev Kevin Dennis bought shares of ZBB stock.

CorMedix Inc. (CRMD): CFO, Treasurer and Secretary Brian Lenz Bought 14,000 Shares

CFO, Treasurer and Secretary of CorMedix Inc. (CRMD) Brian Lenz bought 14,000 shares on 12/14/2011 at an average price of $0.34. CorMedix Inc. is a development-stage pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and renal dysfunction, also known as cardiorenal disease. Cormedix Inc. has a market cap of $4.1 million; its shares were traded at around $0.3399.

CorMedix Inc. announced results for the third quarter ended Sept. 30, 2011. The net loss for the three months ended September 30, 2011 was $2.6 million, or $0.23 per diluted share, compared to a net loss of $1.4 million, or $0.12 per diluted share, for the third quarter 2010.

CFO, Treasurer and Secretary Brian Lenz, Director Steven W. Lefkowitz, and Director James Lefkowitz bought shares of CRMD stock.

Valeant Pharmaceuticals International Inc. (VRX): Executive Vice President and CFO Howard Bradley Schiller Bought 11,000 Shares

Executive Vice President and CFO of Valeant Pharmaceuticals International Inc. (VRX) Howard Bradley Schiller bought 11,000 shares on 12/08/2011 at an average price of $45.51. Valeant Pharmaceuticals International, Inc. is a pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. Valeant Pharmaceuticals International Inc. has a market cap of $13.25 billion; its shares were traded at around $45.33 with a P/E ratio of 19.5 and P/S ratio of 11.2.

CEO J. Michael Pearson, EVP and CFO Howard Bradley Schiller, and Executive Vice President Administration and CHCO Brian M. Stolz bought shares of VRX stock.

For the complete list of stocks that bought by their CFOs, go to: Insider Buys.

Rating: 3.3/5 (10 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK